A Study to Evaluate the Effectiveness and Patient-Reported Outcome of Adalimumab in Patients With Moderate to Severe Plaque Psoriasis in China
Study Identifier
P15-986
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
18 - 99 Years
Protocol Summary
The objective of this non-interventional, observational study is to assess the effectiveness and patient reported outcome of adalimumab in patients with moderate to severe psoriasis in real world clinical practice in China.
Study Locations
Location
Status
Location
The First Affiliated Hospital /ID# 171398
Hefei, Anhui, China, 230031
Status
Not applicable
Location
Guangzhou 1st Muni People Hosp /ID# 208858
Guangzhou, Guangdong, China, 510030
Status
Not applicable
Location
Ruijin Hospital, Shanghai Jiaotong /ID# 169833
Shanghai, Shanghai Municipality, China, 200025
Status
Not applicable
Location
Traditional Chinese Medical Hospital of xinjiang uygur autonomous region /ID# 209183
Ürümqi, Xinjiang, China, 830099
Status
Not applicable
Location
The Second Affiliated Hospital /ID# 169842
Hangzhou, Zhejiang, China, 310009
Status
Not applicable
Location
Sir Run Run Shaw Hospital /ID# 169834
Jianggan Hangzhou, Zhejiang, China, 310018
Status
Not applicable
Showing {first} - {last} of {total} Results